Abstract:Transmembrane member 16A (TMEM16A) is a widely expressed Ca2+-activated Cl- channel with various physiological functions ranging from mucosal secretion to regulating smooth muscle contraction. Understanding how TMEM16A controls these physiological processes and how its dysregulation may cause disease requires a detailed understanding of how cellular processes and second messengers alter TMEM16A channel gating. Here we assessed the regulation of TMEM16A gating by recording Ca2+-evoked Cl- currents conducted by endogenous TMEM16A channels expressed in Xenopus laevis oocytes, using the inside-out configuration of the patch clamp technique. During continuous application of Ca2+, we found that TMEM16A-conducted currents decay shortly after patch excision. Such current rundown is common among channels regulated by phosphatidylinositol 4,5-bisphosphate (PIP2). Thus, we sought to investigate a possible role of PIP2 in TMEM16A gating. Consistently, synthetic PIP2 rescued the current after rundown, and the application of PIP2 modulating agents altered the speed kinetics of TMEM16A current rundown. First, two PIP2 sequestering agents, neomycin and anti-PIP2, applied to the intracellular surface of excised patches sped up TMEM16A current rundown to nearly twice as fast. Conversely, rephosphorylation of phosphatidylinositol (PI) derivatives into PIP2 using Mg-ATP or inhibiting dephosphorylation of PIP2 using β-glycerophosphate slowed rundown by nearly 3-fold. Our results reveal that TMEM16A regulation is more complicated than it initially appeared; not only is Ca2+ necessary to signal TMEM16a opening, but PIP2 is also required. These findings improve our understanding of how the dysregulation of these pathways may lead to disease and suggest that targeting these pathways could have utility for potential therapies.

The TMEM16A channel as a potential therapeutic target in vascular disease

TMEM175: A Lysosomal Ion Channel Associated with Neurological Diseases

Insights into the function and regulation of the calcium-activated chloride channel TMEM16A

TMEM63 mechanosensitive ion channels: Activation mechanisms, biological functions and human genetic disorders

TMEM16 proteins: Ca2+‑activated chloride channels and phospholipid scramblases as potential drug targets (Review)

A comprehensive search for calcium binding sites critical for TMEM16A calcium-activated chloride channel activity

Mitochondria-associated membrane-modulated Ca<SUP>2+</SUP> transfer: A potential treatment target in cardiac ischemia reperfusion injury and heart failure

Modulating Ca2+ signals: a common theme for TMEM16, Ist2, and TMC

TMEM16A ion channel: A novel target for cancer treatment

Transmembrane proteins with unknown function (TMEMs) as ion channels: electrophysiological properties, structure, and pathophysiological roles

A Pharmacological Investigation of the TMEM16A Currents in Murine Skeletal Myogenic Precursor Cells

Research progress on TMEM16F and related diseases

The Natural Compound Cinnamaldehyde is a Novel Activator of Calcium-Activated Chloride Channel

Identification of a druggable pocket of the calcium-activated chloride channel TMEM16A in its open state

Canonical Transient Receptor Potential (TRPC) Channels in Cardiovascular Pathology and their Modulators

Phosphatidylinositol 4,5-bisphosphate (PIP2) and Ca2+ are both required to open the Cl− channel TMEM16A

Divalent Cation Modulation of Ion Permeation in TMEM16 Proteins

Anoctamin Pharmacology

TMEM16A Inhibition Preserves Blood-Brain Barrier Integrity After Ischemic Stroke.

The Ca<SUP>2+</SUP>-activated chloride channel ANO1/TMEM16A: An emerging therapeutic target for epithelium-originated diseases?

Niclosamide potentiates TMEM16A and induces vasoconstriction